Privia Health Group (NASDAQ:PRVA) Price Target Raised to $28.00 at JPMorgan Chase & Co.

Privia Health Group (NASDAQ:PRVA) had its target price hoisted by JPMorgan Chase & Co. from $27.00 to $28.00 in a research note issued to investors on Friday morning,Benzinga reports. They currently have an overweight rating on the stock.

Several other equities analysts have also weighed in on the company. Robert W. Baird lifted their price target on Privia Health Group from $23.00 to $24.00 and gave the company an “outperform” rating in a research note on Monday, August 26th. Barclays upped their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research note on Friday, November 8th. Truist Financial lifted their price target on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Royal Bank of Canada reissued an “outperform” rating and issued a $28.00 price target on shares of Privia Health Group in a report on Wednesday, August 14th. Finally, KeyCorp assumed coverage on shares of Privia Health Group in a report on Friday, October 11th. They set an “overweight” rating and a $23.00 price objective on the stock. Two research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Buy” and a consensus target price of $24.93.

Privia Health Group Stock Performance

PRVA stock opened at $21.48 on Friday. Privia Health Group has a one year low of $15.92 and a one year high of $24.30. The firm’s fifty day moving average is $19.24 and its 200 day moving average is $18.69. The firm has a market cap of $2.58 billion, a PE ratio of 214.82, a P/E/G ratio of 5.45 and a beta of 0.76.

Insiders Place Their Bets

In related news, CEO Parth Mehrotra sold 135,142 shares of the stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This trade represents a 35.29 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 14.20% of the company’s stock.

Institutional Trading of Privia Health Group

Several large investors have recently added to or reduced their stakes in the stock. Sequoia Financial Advisors LLC boosted its position in shares of Privia Health Group by 2.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 26,246 shares of the company’s stock valued at $478,000 after acquiring an additional 583 shares during the last quarter. Benjamin F. Edwards & Company Inc. raised its stake in Privia Health Group by 8.5% during the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,695 shares of the company’s stock worth $134,000 after purchasing an additional 605 shares during the period. Arizona State Retirement System boosted its holdings in Privia Health Group by 2.4% in the 2nd quarter. Arizona State Retirement System now owns 26,574 shares of the company’s stock valued at $462,000 after purchasing an additional 617 shares during the last quarter. Signaturefd LLC grew its stake in shares of Privia Health Group by 46.3% in the 2nd quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock valued at $34,000 after buying an additional 626 shares during the period. Finally, Parkside Financial Bank & Trust increased its holdings in shares of Privia Health Group by 9.7% during the 2nd quarter. Parkside Financial Bank & Trust now owns 8,684 shares of the company’s stock worth $151,000 after buying an additional 771 shares during the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.